Based on data from the past 90 days ending February 19, 2026, Edwards Lifesciences's three largest insider shareholders are Director Michael A Mussallem (4.04Mn shares), Cvp And Chief Financial Officer Scott B. Ullem (306.02K shares), Global President Tavr & Surg Larry L Wood (206.90K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Michael A Mussallem | 4,042,863 | 02 May, 2024 | |
| Scott B. Ullem | Cvp And Chief Financial Officer | 306,017 | 17 Feb, 2026 |
| Larry L Wood | Global President Tavr & Surg | 206,900 | 18 Aug, 2025 |
| Jean-Luc M Lemercier | Cvp And Emeacla And Japac | 184,686 | 08 Jul, 2024 |
| Donald E Jr Bobo | Cvp Andstrategy/Corp Development | 143,475 | 06 Jan, 2026 |
| Huimin Wang | Cvp And Japan & Intercontinental | 99,381 | 08 Jul, 2022 |
| Bernard J Zovighian | Ceo | 92,493 | 13 Feb, 2026 |
| Catherine M. Szyman | Cvp And Critical Care | 81,287 | 03 Sep, 2024 |
| Nicholas J Valeriani | 79,296 | 09 May, 2025 | |
| Kieran Gallahue | 71,901 | 09 May, 2025 | |
| Steven R Loranger | 65,054 | 09 May, 2025 | |
| Robert W.A. Sellers | Svp And Corporate Controller | 37,490 | 13 May, 2024 |
| Daniel J. Lippis | Cvp And Tavr | 34,366 | 17 Feb, 2026 |
| Daveen Chopra | Cvp And Tmtt & Surgical | 32,201 | 11 Dec, 2025 |
| Martha H. Marsh | 31,880 | 15 May, 2023 | |
| Heisz Leslie Stone | 30,948 | 12 Dec, 2025 | |
| Wayne Markowitz | Cvp And Japac | 17,563 | 08 Dec, 2025 |
| Paul A Laviolette | 14,301 | 09 May, 2025 | |
| Annette Bruls | Cvp And Emeacla | 14,171 | 11 Jul, 2025 |
| Ramona Sequeira | 11,686 | 09 May, 2025 | |
| Andrew M. Dahl | Svp And Corporate Controller | 9,183 | 13 Nov, 2025 |
| Leslie C. Davis | 6,583 | 09 May, 2025 | |
| David T Feinberg | 5,836 | 09 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Feb, 2026 | Daniel J. Lippis | Common Stock | D | 198 | $75.87 | 34,366 | D | F |
| 16 Feb, 2026 | Scott B. Ullem | Common Stock | D | 199 | $75.87 | 39,699 | D | F |
| 16 Feb, 2026 | Daniel J. Lippis | Common Stock | D | 258 | $75.87 | 34,564 | D | F |
| 13 Feb, 2026 | Bernard J Zovighian | Common Stock | A | 2,920 | $0.00 | 11,517 | I | G |
| 13 Feb, 2026 | Bernard J Zovighian | Common Stock | D | 2,920 | $0.00 | 80,976 | D | G |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | D | 2,532 | $77.13 | 103,794 | D | S |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | D | 19,898 | $76.61 | 83,896 | D | S |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | A | 25,350 | $59.26 | 106,326 | D | M |
| 12 Feb, 2026 | Daniel J. Lippis | Common Stock | A | 12,820 | $0.00 | 34,822 | D | A |
| 09 Jan, 2026 | Daniel J. Lippis | Common Stock | A | 1,019 | $59.26 | 23,021 | D | M |
| 09 Jan, 2026 | Daniel J. Lippis | Common Stock | D | 1,019 | $85.70 | 22,002 | D | S |
| 06 Jan, 2026 | Donald E Jr Bobo | Common Stock | A | 11,340 | $59.26 | 43,210 | D | M |
| 06 Jan, 2026 | Donald E Jr Bobo | Common Stock | D | 2,632 | $84.62 | 40,578 | D | S |
| 06 Jan, 2026 | Donald E Jr Bobo | Common Stock | D | 8,708 | $85.98 | 31,870 | D | S |
| 12 Dec, 2025 | Donald E Jr Bobo | Common Stock | D | 7,100 | $0.00 | 31,870 | D | G |
| 12 Dec, 2025 | Donald E Jr Bobo | Common Stock | D | 5,900 | $83.74 | 38,970 | D | S |
| 12 Dec, 2025 | Donald E Jr Bobo | Common Stock | D | 5,486 | $83.79 | 44,870 | D | S |
| 12 Dec, 2025 | Heisz Leslie Stone | Common Stock | D | 2,615 | $83.41 | 30,948 | D | S |
| 12 Dec, 2025 | Heisz Leslie Stone | - | - | 30,948 | D | |||
| 12 Dec, 2025 | Daniel J. Lippis | Common Stock | D | 1,019 | $84.03 | 22,002 | D | S |